Press Release: Weave Announces Date of Third Quarter 2024 Financial Results and Conference Call

Dow Jones
2024-10-17

Weave Announces Date of Third Quarter 2024 Financial Results and Conference Call

LEHI, Utah--(BUSINESS WIRE)--October 16, 2024-- 

Weave $(WEAV)$, a leading all-in-one customer experience software and payments platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the third quarter 2024 after U.S. markets close on Wednesday, October 30, 2024. Company management will host a conference call and webcast at 4:30 p.m. ET to discuss Weave's financial results and provide a business update.

Individuals interested in listening to the conference call may do so by dialing (862) 298-0702 or toll-free at (888) 645-4404. The live webcast and a webcast replay of the conference call can be accessed from the investor relations page of Weave's website at investors.getweave.com.

About Weave

Weave is the all-in-one customer experience software and payments platform for small- and medium-sized healthcare businesses. From the first phone call to the final invoice and every touchpoint in between, Weave connects the entire customer journey. Weave's software solutions transform how local businesses attract, communicate with, and engage customers to grow their business. In the past year, Weave has been named a G2 leader in Patient Engagement, Optometry, Dental Practice Management, and Patient Relationship Management software. To learn more, visit getweave.com/newsroom/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241016947994/en/

 
    CONTACT:    Investor Contact: 

Mark McReynolds

Head of Investor Relations

ir@getweave.com

Media Contact:

Natalie House

Senior Director of Content & Communications

pr@getweave.com

 
 

(END) Dow Jones Newswires

October 16, 2024 19:02 ET (23:02 GMT)

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10